Characteristics of included studies
Study | Country | Design | Study period | Size | Male (%) | Age, years | Level of experience | HUD |
Aldaas et al 21 | USA | Consecutive | NR | 70 | 50 | 61±18 | Both | Vscan |
Alexander et al 22 | USA | NR | April–November 2000 | 537 | 53 | 59 | Inexperienced | Optigo |
Andersen et al 23 | Norway | Random | March–September 2010 | 108 | 64 | 69.1±14 | Experienced | Vscan |
Biais et al 24 | France | Consecutive | February–May 2011 | 151 | 35 | 55±20 | Experienced | Vscan |
Bruce et al 9 | USA | NR | NR | 374 | 62 | 66 | Both | SonoHeart |
Coletta et al 25 | Italy | Consecutive | April–June 2003 | 112 | 57 | 61±11 | Experienced | Optigo |
Cullen et al 26 | USA | Consecutive | 2012–2013 | 190 | 49 | 62±17 | Experienced | Vscan |
DeCara et al 27 | USA | NR | NR | 300 | NR | NR | Experienced | Optigo |
Fedson et al 28 | USA | Consecutive | NR | 103 | NR | NR | Inexperienced | Optigo |
Galasko8 | UK | Consecutive | 2000–2001 | 562 | 56 | 62±11 | Experienced | Optigo |
Ghani et al 29 | USA | Consecutive | NR | 80 | 51 | 75±13 | Inexperienced | Optigo |
Giusca et al 30 | Romania | Consecutive | NR | 56 | 54 | 60±12 | Inexperienced | Acuson P10 |
Gulič et al 31 | Slovenia | Consecutive | NR | 200 | 43 | 70 | Both | Vscan |
Khan32 | USA | Consecutive | 2012–2013 | 240 | 53 | 71±17 | Experienced | Vscan |
Kirkpatrick33 | USA | NR | NR | 63 | 46 | 65±16 | Inexperienced | Optigo |
Kobal et al 34 | USA | Consecutive | NR | 61 | 62 | 70±19 | Inexperienced | Optigo |
Liebo35 | USA | Consecutive | February–March 2010 | 97 | 45 | 68±17 | Both | Vscan |
López-Palmero et al 36 | Spain | NR | July–December 2013 | 223 | 42 | 76 | Inexperienced | Vscan |
Lucas et al 37 | USA | Consecutive | March–May 2007 | 322 | 53 | 56±13 | Inexperienced | Micromaxx |
Lucas et al 38 | USA | Consecutive | 2008–2009 | 210 | 55 | 55 | Inexperienced | NR |
Martin et al 39 | USA | Consecutive | 2004–2005 | 354 | 47 | 63±19 | Inexperienced | Sonosite Elite |
Mehta et al 40 | USA | NR | NR | 250 | 66 | 61±15 | Experienced | Vscan |
Mjølstad et al 41 | Norway | Consecutive | April–June 2011 | 199 | 54 | 66±18 | Inexperienced | Vscan |
Nilsson et al 42 | Sweden | NR | 2016–2017 | 100 | 55 | 70±12 | Inexperienced | Vscan |
Olesen43 | Denmark | NR | NR | 260 | 49 | 80 | Experienced | Vscan |
Perez-Avraham et al 44 | Israel | Consecutive | July–December 2004 | 85 | 37 | 59±14 | Inexperienced | Optigo |
Razi et al 45 | USA | Consecutive | NR | 50 | 58 | 57±17 | Inexperienced | Vscan |
Ruddox et al 46 | Norway | NR | 2011–2012 | 303 | 61 | 73 | Inexperienced | Vscan |
Stokke et al 13 | Norway | Random | February–May 2012 | 72 | 72 | 65±16 | Both | Vscan |
Vignon et al 47 | France | Consecutive | NR | 55 | 69 | 61±16 | Experienced | SonoHeart |
Vourvouri et al 48 | The Netherlands | Consecutive | NR | 88 | 64 | 59±12 | Experienced | SonoHeart or Optigo |
Wejner-Mik et al 49 | Poland | Consecutive | NR | 87 | 67 | 61±16 | Experienced | Lumify |
Xie et al 50 | USA | Consecutive | NR | 100 | 55 | 59±17 | Experienced | SonoHeart |
HUD, handheld ultrasound devices; NR, not reported.